Background Statins are widely used to treat people with metabolic and cardiovascular
disorders. The effect of statins on coronavirus disease 2019 (COVID-19) is unclear. To …

There is mounting evidence that statin use is beneficial for COVID-19 outcomes. We
performed a systematic review and meta-analysis to evaluate the association between statin …

Introduction Statins may reduce a cytokine storm, which has been hypothesized as a
possible mechanism of severe COVID-19 pneumonia. The aim of this study was to conduct a …

Background and aims Statin therapy is administered to patients with high cardiovascular
risk. These patients are also at risk for severe course of coronavirus disease 2019 (COVID …

Purpose Previously, we have reported potential clinical benefits with the use of statins in
patients with coronavirus disease 2019 (COVID-19) in a meta-analysis, where there was a …

Background and aims The idea of treating COVID-19 with statins is biologically plausible,
although it is still controversial. The systematic review and meta-analysis aimed to address …

Background There is an urgent need for novel therapeutic strategies for reversing COVID-19-
related lung inflammation. Recent evidence has demonstrated that the cholesterol-lowering …

Objectives There is conflicting evidence about the efficacy of statin use in regard to clinical
outcomes in patients with coronavirus disease 2019 (COVID-19). A systematic review and …

Background: Recent epidemiological studies remain controversial regarding the association
between statin use and reducing the risk of mortality among individuals with COVID-19 …

Purpose Observations studies have shown that prior use of statins is associated with a
reduced risk of adverse clinical outcomes in patients with COVID-19. However, the available …